Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

carcinoembryonic antigen peptide 1-6D

A 9-residue human leukocyte antigen (HLA)-restricted fragment of carcinoembryonic antigen (CEA). Vaccination with carcinoembryonic antigen peptide 1-6D, which has the amino acid sequence YLSGANLNL, may elicit a cytotoxic T lymphocyte (CTL) immune response against tumors expressing CEA.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:CEA:571-579 (576D)
mCEA peptide
modified CEA peptide
Abbreviation:CAP-1-6D peptide
CEA PEP 1-6D
IND number:6843
NSC code:701524
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search